Hookipa Pharma Inc

HOOK NASDAQ
6.70
-0.21
-3.04%
Opening 12:23 07/23 EDT
Open
6.91
Prev Close
6.91
High
6.92
Low
6.28
Volume
57.92K
Avg Vol (3M)
117.88K
52 Week High
14.76
52 Week Low
6.06
% Turnover
0.22%
Market Cap
174.70M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Hookipa Pharma Inc HOOK stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is developing products to prevent and cure infectious diseases and cancer. The Company's infectious and oncology product candidates HB-101, HB-201 and HB-202. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company offers VaxWave technology, which is designed to induce a robust CD8+ T cell and pathogen neutralizing response to fight disease. VaxWave technology supports the benefits of our arenavirus platform approach.
MORE >

Recently

Name
Price
%Change